Apparent differences in mechanisms of harmol sulfate biliary excretion in mice and rats. - Wikidata - awgldk - TriplyDB

Apparent differences in mechanisms of harmol sulfate biliary excretion in mice and rats.

Apparent differences in mechanisms of harmol sulfate biliary excretion in mice and rats.

http://www.wikidata.org/entity/Q37132937

about

Hepatocellular exposure of troglitazone metabolites in rat sandwich-cultured hepatocytes lacking Bcrp and Mrp2: interplay between formation and excretion.Decreased hepatic breast cancer resistance protein expression and function in multidrug resistance-associated protein 2-deficient (TR⁻) rats Glucuronidation: driving factors and their impact on glucuronide disposition

P2860

Q33742713-FB1FB303-E8D5-4B81-B3F8-F2CB69DA44ED Q34702620-301E7D76-640E-42AF-A396-8235CB84278E Q56030213-06D9CA20-9A92-4B38-B3B2-B83996F25CFB

P2860

Apparent differences in mechanisms of harmol sulfate biliary excretion in mice and rats.

http://www.wikidata.org/entity/Q37132937

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 August 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Apparent differences in mechanisms of harmol sulfate biliary excretion in mice and rats.

@en

Apparent differences in mechanisms of harmol sulfate biliary excretion in mice and rats.

@nl

type

label

Apparent differences in mechanisms of harmol sulfate biliary excretion in mice and rats.

@en

Apparent differences in mechanisms of harmol sulfate biliary excretion in mice and rats.

@nl

prefLabel

Apparent differences in mechanisms of harmol sulfate biliary excretion in mice and rats.

@en

Apparent differences in mechanisms of harmol sulfate biliary excretion in mice and rats.

@nl

P1433

Q37132937-DFE4A28B-CD46-4FFF-B9D1-2019F84E734C

P1476

Q37132937-D78B06CB-AA38-4F47-98F6-C4BD49141F21

P2093

Q37132937-2B2D6862-66E7-4651-85C6-260EB9C59A2A

Q37132937-41714F20-2261-4B4F-A612-979EEE275FF5

Q37132937-88646075-ED35-4927-B22F-89F5E80C13A6

Q37132937-A276E869-70FC-460E-A70A-A8044B2B01D0

P2860

Q37132937-11BACCC0-FD70-4721-BFC6-0C9166093372

Q37132937-2563F97B-40E7-47A3-B8DB-BFF34BABEA93

Q37132937-312C7F52-8A11-44FF-81AB-DECA98CF118A

Q37132937-39E47571-1851-45CD-BC8B-88C7EF5E08FA

Q37132937-5844412B-0470-4CAD-88BD-2207D48C2C81

Q37132937-71D8B1B4-85EC-489C-838E-7069D3D3342A

Q37132937-78C2761E-DF9A-45E2-A5C8-0F76E17035D7

Q37132937-801B06B1-E8F3-4D2A-9B62-E012D2E5C929

Q37132937-9B0D6845-6B44-454F-8A5C-BACDB74C1AB7

Q37132937-B9D4DDEF-77B7-4331-B2B9-2216F4816531

P304

Q37132937-652A5CDF-52DD-4E7F-BE61-888F151495FE

P31

Q37132937-A0D8ACCF-6D50-4FA2-B6A8-709500267203

P356

Q37132937-B87638F6-D03F-4E51-AAC7-CE9BE8F2FAD4

P433

Q37132937-7F62CAA4-D017-4DB6-B599-82EFB8D7DD0F

P478

Q37132937-59F2660C-1D0C-4D68-A69E-B534E4656152

P577

Q37132937-28F88710-56BA-4662-B639-79E19B47470F

P5875

Q37132937-DEED15ED-8E05-4042-AA60-447613D5EEB4

P698

Q37132937-1ED3CEC5-A7D3-4932-A1E4-E464289D69B1

P932

Q37132937-88FE9EF3-7088-4223-AB7A-325DD2692CAE

P356

P1433

Drug Metabolism and Disposition

P1476

Apparent differences in mechanisms of harmol sulfate biliary excretion in mice and rats.

@en

P2093

Keith A Hoffmaster

http://www.w3.org/2001/XMLSchema#string

Ken-ichi Nezasa

http://www.w3.org/2001/XMLSchema#string

Kim L R Brouwer

http://www.w3.org/2001/XMLSchema#string

Maciej J Zamek-Gliszczynski

http://www.w3.org/2001/XMLSchema#string

P2860

Differential involvement of Mrp2 (Abcc2) and Bcrp (Abcg2) in biliary excretion of 4-methylumbelliferyl glucuronide and sulfate in the rat

Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: in vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat.

Mice lacking multidrug resistance protein 3 show altered morphine pharmacokinetics and morphine-6-glucuronide antinociception.

Transport, binding, and metabolism of sulfate conjugates in the liver.

Integration of hepatic drug transporters and phase II metabolizing enzymes: mechanisms of hepatic excretion of sulfate, glucuronide, and glutathione metabolites.

ABCG2 transports sulfated conjugates of steroids and xenobiotics.

Retrograde perfusion to probe the heterogeneous distribution of hepatic drug metabolizing enzymes in rats.

UDP glucuronyltransferase and phenolsulfotransferase from rat liver in vivo and in vitro--IV. Species differences in harmol conjugation and elimination in bile and urine in vivo.

The effect of troglitazone biliary excretion on metabolite distribution and cholestasis in transporter-deficient rats.

Hepatobiliary disposition of the metabolically stable opioid peptide [D-Pen2, D-Pen5]-enkephalin (DPDPE): pharmacokinetic consequences of the interplay between multiple transport systems.

P304

2156-2158

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1124/DMD.108.022053

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P577

2008-08-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23186294

http://www.w3.org/2001/XMLSchema#string

P698

18719241

http://www.w3.org/2001/XMLSchema#string

P932

2657472

http://www.w3.org/2001/XMLSchema#string